News Flash: The winner of the #Convaidgives Rodeo giveaway contest is Fletcher with 731 likes and 470 shares, followed by Brandon, Li Ru, Mary, Cary Anne and Sarah’s family! Fletcher will get a Rodeo in the color of his choice and the top four participants who received honorable mentions will receive a Scallop by R82 or an accessory for their current #Convaid product!

For those who did not win this time around, stay tuned to our Social Media pages for new contests featuring R82 Convaid products.

The new Rodeo by Convaid without and with seat options

The new Rodeo by Convaid without and with seat options

For those of you near Los Angeles, we look forward to seeing you at Abilities Expo Los Angeles from March 24-26, 2017 at the Los Angeles Convention Center.  Special guests will attend on Saturday, March 25th.

Fletcher will be fitted for the new Rodeo by Convaid, the leader in tilt-in-space, compact-folding, lightweight and durable positioning systems. The new Rodeo is perfect for someone who needs more involved positioning and support. Two frame options – with and without seating – allow for adaptive and more extensive seating options with 5° to 45° of adjustable tilt and 90° or 110° of adjustable recline provide pressure relief and upper body support and dynamic positioning promotes increased sitting tolerance. Custom built to individual user’s needs, the Rodeo’s adjustable seat depth extends chair life for a growing child, providing 5 years of growth capabilities. Foot and leg positioning options include a one-piece footplate or individual, angle adjustable footplates, a padded footbox for comfort and safety, and an elevating leg rest. Numerous pelvic, trunk and head support positioning options help to ensure the best, most therapeutic and comfortable fit. The easy clamshell fold-flat design and adjustable tension upholstery make the Rodeo a top choice for both users and caregivers. The Rodeo has a transit-ready option, and has met WC19 safety standards for safe transportation.

 

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *